Moderna was in focus after updated cancer vaccine data, while Novavax drew attention following its Pfizer licensing deal. ・Retail sentiment on Stocktwits was ‘extremely bullish’ for both stocks, with …
MRNA vs. NVAX: Which vaccine stock is Wall Street more bullish on right now?
view original post